Non-kinase inflammatory pathway

The term Non-kinase inflammatory pathway does not refer to a single molecular target, receptor, or enzyme, but rather describes a broad category of biological signaling processes that drive inflammation without relying primarily on protein kinase activity. This category encompasses diverse mechanisms such as the activation of the NLRP3 inflammasome, the cyclooxygenase (COX) mediated synthesis of prostaglandins, and the direct action of transcription factors or ion channels in immune cells. In the context of drug discovery, this term is often used to distinguish therapeutic strategies from the widely used kinase inhibitors, such as JAK or MAPK inhibitors. Because it represents a collection of pathways rather than a specific protein, it cannot be targeted by a single drug with a uniform mechanism of action. For precise therapeutic development, specific components within these pathways, such as Interleukin-1 beta or Toll-like receptors, must be identified as the actual targets.

Other names

Non-kinase signalingKinase-independent inflammatory signaling

Not applicable as this is a broad category of pathways rather than a single molecular target.